Cancer outcomes research—a European challenge: measures of the cancer burden-Reference-Cited by-同舟云学术

Cancer outcomes research—a European challenge: measures of the cancer burden

Published:2021-06-22 Issue:12 Volume:15 Page:3225-3241
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Kalager Mette¹^ORCID,Adami Hans‐Olov¹²,Lagergren Pernilla³⁴,Steindorf Karen⁵,Dickman Paul W.²

Affiliation:

1. Clinical Effectiveness Research Group University of Oslo and Oslo University Hospital Norway

2. Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

3. Surgical Care Science Department of Molecular Medicine and Surgery Karolinska Institutet Karolinska University Hospital Stockholm Sweden

4. Department of Surgery and Cancer Imperial College London UK

5. Division of Physical Activity, Prevention and Cancer National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ) Heidelberg Germany

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13012

Reference54 articles.

1. European Academy of Cancer Sciences – position paper

2. Mammography screening: A major issue in medicine

3. Mission‐oriented translational cancer research – health economics

4. Cancer survivorship: an integral part of Europe's research agenda

5. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects;Frontiers in Immunology;2024-08-23

2. In silico and in vitro analyses to investigate the effects of vitamin C on VEGF protein;Journal of Taibah University Medical Sciences;2024-08

3. Outcome Reporting in Onco-Anaesthesiology and Perioperative Medicine;Journal of Onco-Anaesthesiology and Perioperative Medicine;2024-05

4. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths;Cancer Causes & Control;2024-01-18

5. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems;Heliyon;2024-01